You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ak112

Showing 1 - 17 of 17
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Non-small-cell Lung Cancer Trial in Shanghai (AK112, AK104, caboplatin)

Not yet recruiting
  • Advanced Non-small-cell Lung Cancer
  • AK112
  • +5 more
  • Shanghai, China
    Shanghai Pulmonary Hospital
Jun 6, 2023

Colorectal Cancer Trial in Harbin (AK119, AK112, Oxaliplatin)

Not yet recruiting
  • Colorectal Cancer
  • Harbin, China
    Cancer Hospital Affiliated to Harbin Medical University
May 5, 2023

Solid Tumor, Adult Trial (AK119, AK112)

Not yet recruiting
  • Solid Tumor, Adult
  • (no location specified)
Jan 10, 2023

NSCLC Trial (AK119, AK112, Pemetrexed)

Not yet recruiting
  • NSCLC
  • (no location specified)
Nov 23, 2022

Solid Tumor, Adult Trial in Guangzhou (AK112)

Active, not recruiting
  • Solid Tumor, Adult
  • AK112
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Oct 8, 2022

Metastatic Triple-negative Breast Cancer, Locally Advanced Triple-negative Breast Cancer Trial in Changsha, Xiangyang (AK117,

Recruiting
  • Metastatic Triple-negative Breast Cancer
  • Locally Advanced Triple-negative Breast Cancer
  • Changsha, China
  • +1 more
Sep 8, 2022

SCLC, Extensive Stage Trial in Shanghai (AK112, Etoposide, Carboplatin)

Recruiting
  • SCLC, Extensive Stage
  • AK112
  • +2 more
  • Shanghai, Shanghai, China
    Shun Lu
Oct 12, 2022

Metastatic Colorectal Cancer Trial in Guanzhou (AK112, AK117, Oxaliplatin)

Recruiting
  • Metastatic Colorectal Cancer
  • AK112
  • +7 more
  • Guanzhou, Guangdong, China
    The Sixth Hospital,Sun Yat-sen University
Aug 1, 2022

Gynecologic Cancer, Cancer Metastatic, Ovarian Tumors Trial in Qilu, Chongqing (AK112)

Active, not recruiting
  • Gynecologic Cancer
  • +4 more
  • AK112
  • Qilu, Shandong, China
  • +1 more
Oct 8, 2022

Hepatocellular Carcinoma Trial (AK112)

Not yet recruiting
  • Hepatocellular Carcinoma
  • AK112
  • (no location specified)
Jun 24, 2022

Advanced Non-small-cell Lung Cancer Trial in Shanghai (AK112, Pembrolizumab)

Not yet recruiting
  • Advanced Non-small-cell Lung Cancer
  • Shanghai, China
    Shanghai Pulmonary Hospital
Aug 12, 2022

Tumors Malignant Trial in Australia (AK112)

Recruiting
  • Neoplasms Malignant
  • AK112
  • Albury, New South Wales, Australia
  • +6 more
Oct 26, 2022

Advanced Malignant Tumors Trial in Hangzhou (AK112, AK117, Carboplatin)

Recruiting
  • Advanced Malignant Tumors
  • AK112
  • +4 more
  • Hangzhou, Zhejiang, China
    Zhejiang Cancer Hospital
May 10, 2022

Resectable NSCLC Trial (AK112, Carboplatin, Cisplatin)

Not yet recruiting
  • Resectable Non-small Cell Lung Cancer
  • AK112
  • +3 more
  • (no location specified)
Feb 9, 2022

Advanced Malignant Tumors Trial in Hangzhou (AK112, AK117, Chemotherapy)

Recruiting
  • Advanced Malignant Tumors
  • AK112
  • +2 more
  • Hangzhou, Zhejiang, China
    Zhejiang Cancer Hospital
Jan 27, 2022

NSCLC Trial in Shanghai (AK112)

Recruiting
  • Non-small Cell Lung Cancer
  • AK112
  • Shanghai, Shanghai, China
    Shanghai Pulmonary Hospital
May 23, 2021

NSCLC Trial in Guanzhou (AK112, Pemetrexed, Paclitaxel)

Recruiting
  • NSCLC
  • AK112
  • +5 more
  • Guanzhou, Guangdong, China
    Sun Yat-Sen University Cancer Center
Jan 30, 2021